CVE-2018-14787: Philips IntelliSpace Cardiovascular (ISCV) products vulnerability
Philips · IntelliSpace Cardiovascular (ISCV) products
Affected: Philips IntelliSpace Cardiovascular (ISCV) products · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 33% of scored CVEs
Not scored yet. The CVE record carries no CVSS score.
DescriptionCVE.org
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- Philips · IntelliSpace Cardiovascular (ISCV) productsIntelliSpace Cardiovascular, Version 3.1 or prior; Xcelera Version 4.1 or prior
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Vendor
- Philips
- Published
- August 2018
CoverageNo articles yet
No CyberSIXT article names CVE-2018-14787 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.